Efthymia C. Vlachaki
Thessaloniki, ESYE12, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 93 publications
Hb Thessaloniki, a Novel, Hyperunstable, Alpha Globin Variant Detected in Northern Greece.
Journal: Hematology reports
Published: November 19, 2025
Patients', clinicians' and research's priorities on important outcomes in multiple myeloma: A mixed-methods study.
Journal: British journal of haematology
Published: October 14, 2025
Quantifying Morbidity Risk Attributed to Red-Cell Transfusion Volume in Optimally Transfused Patients With β-Thalassemia.
Journal: American journal of hematology
Published: August 15, 2025
Interplay Between Sickle Cell Disease and Thrombosis: A Single Center Experience of Pathophysiology and Potential Risk Factors.
Journal: Hematology reports
Published: July 05, 2025
Post-Load Plasma Glucose Increase (PG-gap) as a Risk Factor for Developing Dysglycemia in Patients with Transfusion-Dependent β-Thalassemia (β-TDT): Retrospective Analysis over 8 Years.
Journal: Mediterranean journal of hematology and infectious diseases
Published: June 12, 2025
Lifetime Risk of Liver Disease in Patients With β-Thalassemia: Data From the de-LIGHT Retrospective Cohort Study.
Journal: European journal of haematology
Published: April 26, 2025
Pegcetacoplan for the treatment of warm autoimmune hemolytic anemia: a case report.
Journal: Blood cells, molecules & diseases
Published: April 07, 2025
Impact of lifetime anaemia and iron control on outcomes in β-thalassaemia: Data from the longitudinal de-LIGHT study.
Journal: British journal of haematology
Published: March 13, 2025
Lenalidomide Efficacy in Patients with MDS and Del-5q: Real-World Data from the Hellenic (Greek) National Myelodysplastic & Hypoplastic Syndromes Registry (EAKMYS).
Journal: Cancers
Published: February 28, 2025
Prospective Study of ADAMTS13 and von Willebrand Factor's Role in the Prediction of Outcomes in Acute Ischemic Stroke.
Journal: Journal of clinical medicine
Published: February 25, 2025
Real-life experience of luspatercept in transfusion-dependent lower risk myelodysplastic syndrome patients.
Journal: British journal of haematology
Published: January 17, 2025
Last Updated: 09/26/2026